Sign in
4

Changes in Ownership

Immix Biopharma, Inc. Filed Acc 0001493152-23-028477

Options or other derivatives

  • CFO acquired 193,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Morris Gabriel S CFO 2023-08-11 Grant or award · Stock Options +193,000 193,000 D
Loading xslF345X05/ownership.xml…